Generalized necrobiosis lipoidica treated with a combination of split-thickness autografting and immunomodulatory therapy.
Cummins
Deborah L
DL
Department of Dermatology, Johns Hopkins Medical Institutions, Baltimore, MD, USA.
Hiatt
Kim M
KM
Mimouni
Daniel
D
Vander Kolk
Craig A
CA
Cohen
Bernard A
BA
Nousari
Carlos H
CH
D000293:Adolescent; D000893:Anti-Inflammatory Agents / Q000627:therapeutic use*; D003131:Combined Modality Therapy; D000068800:Etanercept; D006801:Humans; D007074:Immunoglobulin G / Q000627:therapeutic use*; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D008297:Male; D009335:Necrobiosis Lipoidica / Q000473:pathology / Q000628:therapy*; D011241:Prednisone / Q000627:therapeutic use*; D018124:Receptors, Tumor Necrosis Factor / Q000627:therapeutic use*; D016038:Skin Transplantation
D000893:Anti-Inflammatory Agents; D007074:Immunoglobulin G; D007166:Immunosuppressive Agents; D018124:Receptors, Tumor Necrosis Factor; D000068800:Etanercept; D011241:Prednisone